Our story and vision in the news
News & Press Releases
May 11, 2023
ClarityX Enhances Max Rx® Test's Capabilities with Additional Reported Medications
ClarityX a leading provider of gene-based medication testing, is proud to announce the expansion of their pharmacogenetic test Max Rx®. The new upgraded test builds upon the popularity and success of the ClarityX Max Rx® Test. A total of 39 new medications have been added.
February 1, 2022
ClarityX Celebrates American Heart Month With DNA Testing
Finding the right treatment option is an essential part of overcoming heart conditions and regaining control of cardiovascular health. Unfortunately, it can be difficult for healthcare providers to pinpoint the best medications for their patients.
January 28, 2022
The Key to Tackling Seasonal Affective Disorder
Recent clinical research has shown that depression spikes at the beginning of the new year, with over 10 million Americans struggling with seasonal depression. Seasonal Affective Disorder (SAD) is a type of depression that relates to changes in the seasons.
December 14, 2021
ClarityX Releases New Mindwell® Test
Over the past few years, there has been an increased focus on the importance of mental health. The National Center for Health Statistics (NCHS) have reported adults showing symptoms of anxiety or depressive disorder in 2020 and 2021, spiked up by 33.9% and 42.4% respectively.
